Prenatal diagnosis--principles of diagnostic procedures and genetic counseling.

Department of Genetics, Wroclaw Medical University, Poland.
Folia Histochemica et Cytobiologica (Impact Factor: 1). 02/2007; 45 Suppl 1:S11-6.
Source: PubMed

ABSTRACT The frequency of inherited malformations as well as genetic disorders in newborns account for around 3-5%. These frequency is much higher in early stages of pregnancy, because serious malformations and genetic disorders usually lead to spontaneous abortion. Prenatal diagnosis allowed identification of malformations and/or some genetic syndromes in fetuses during the first trimester of pregnancy. Thereafter, taking into account the severity of the disorders the decision should be taken in regard of subsequent course of the pregnancy taking into account a possibilities of treatment, parent's acceptation of a handicapped child but also, in some cases the possibility of termination of the pregnancy. In prenatal testing, both screening and diagnostic procedures are included. Screening procedures such as first and second trimester biochemical and/or ultrasound screening, first trimester combined ultrasound/biochemical screening and integrated screening should be widely offered to pregnant women. However, interpretation of screening results requires awareness of both sensitivity and predictive value of these procedures. In prenatal diagnosis ultrasound/MRI searching as well as genetic procedures are offered to pregnant women. A variety of approaches for genetic prenatal analyses are now available, including preimplantation diagnosis, chorion villi sampling, amniocentesis, fetal blood sampling as well as promising experimental procedures (e.g. fetal cell and DNA isolation from maternal blood). An incredible progress in genetic methods opened new possibilities for valuable genetic diagnosis. Although karyotyping is widely accepted as golden standard, the discussion is ongoing throughout Europe concerning shifting to new genetic techniques which allow obtaining rapid results in prenatal diagnosis of aneuploidy (e.g. RAPID-FISH, MLPA, quantitative PCR).

Download full-text


Available from: Ryszard Slezak, Jun 30, 2015
  • Source
    Dataset: RAS
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The option of surgical fetal intervention (SFI) for the treatment of fetal anomalies is relatively new. It is generally recommended for anatomic problems that cause ongoing damage to either the developing fetus or the mother. It is important that parents considering SFI receive counseling from a medical professional before making a decision; prenatal genetic counselors are in an ideal position to do this. This study was designed to assess prenatal genetic counselors’ current knowledge, experience, and comfort level with SFI, and to compare two groups of counselors: those who work in a fetal intervention setting and those who do not. We recruited prenatal genetic counselors through the National Society of Genetic Counselors (NSGC) Listserv who had a minimum of one year of clinical experience and saw patients at least eight hours per week to take a quantitative survey. The survey consisted of multiple choice, Likert scale, and open-ended questions. We collected the survey data in SPSS and completed ANOVA and correlation analysis. We received 82 completed surveys: 28 from fetal intervention counselors and 54 from general prenatal counselors. All respondents were aware of SFI and 84% reported experience counseling for SFI. However, we found a wide range of knowledge levels from questions on details about the surgeries and the use of SFI for specific fetal anomalies. Those counselors who worked in a fetal intervention setting had significantly higher overall knowledge and comfort scores, but not experience scores. We found that 61.3% of respondents first learned about SFI in their genetic counseling training, but 41.5% felt their program did not prepare them well to counsel for it. Our findings indicate that there is a need for genetic counseling programs to increase the amount of time they spend teaching about SFI. It also indicates a need for educational materials and learning opportunities for practicing genetic counselors. Brandeis University, Graduate School of Arts and Sciences
  • [Show abstract] [Hide abstract]
    ABSTRACT: To report the first case of prophylactic laser treatment to prevent blindness in a patient who was diagnosed with Norrie's disease by genetic testing with amniocentesis. Case report. A 2-year-old white boy with Norrie's disease. A 37-week gestational age male with a family history of Norrie's disease was born via Cesarean section after the mother had undergone prenatal amniocentesis fetal-genetic testing at 23 weeks of gestation. A C520T (nonsense) mutation was found in the Norrie's disease gene. After examination under anesthesia confirmed the diagnosis on the first day of life, laser photocoagulation was applied to the avascular retina bilaterally. The patient was followed closely by ophthalmology, pediatrics, and occupational therapy departments. Functional outcome, as documented by Teller visual acuity and formal occupational therapy testing, and anatomic outcome, as documented by Retcam photography and fluorescein angiography. Complete regression of extraretinal fibrovascular proliferation was observed 1 month after laser treatment. No retinal detachment had occurred to date at 24 months. Teller visual acuity at 23 months of life was 20/100 in both eyes. The patient's vision and developmental milestones were age appropriate. Pre-term genetic diagnosis with immediate laser treatment after birth may preserve vision in individuals affected with Norrie's disease.
    Ophthalmology 12/2010; 117(12):2402-6. DOI:10.1016/j.ophtha.2010.03.057 · 6.17 Impact Factor